A*Star
A*STAR Wins $2M Chan Zuckerberg Initiative Grant to Advance Asian Immune Cell Atlas
The Asian Immune Diversity Atlas aims to sequence millions of peripheral blood mononuclear cells from over 2,000 healthy ancestrally diverse Asian people.
MiRxes Raises $77M in Series C Round to Speed Progress of Early Cancer Detection Tests
The Singapore-based company's tests look for blood-borne microRNA and other molecular signatures released by cancer and immune cells.
Avatamed, A*STAR Launch Joint Precision Oncology Lab in Singapore
Together with Singapore's Agency for Science, Technology, and Research, Avatamed will offer its drug screening platform to oncologists and drugmakers.
Singapore Precision Medicine Program to Analyze Genetics of 150K Citizens
The program is part of a 10-year initiative focused on establishing the frameworks and infrastructure to roll out precision medicine throughout the country.
Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform
The partners believe the platform, which captures high resolution images of CTCs and clusters, has potential applications in early cancer detection and disease monitoring.